Stocks and Investing Stocks and Investing
Tue, March 2, 2021
[ 12:00 AM ] - WOPRAI
Daniel Ives Maintained (AI) at Buy with Decreased Target to $175 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (AI) at Hold with Decreased Target to $120 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Brandon Nispel Upgraded (AKAM) to Buy and Held Target at $119 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Initiated (TERN) at Strong Buy and Held Target at $29 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Ritu Baral Initiated (TERN) at Buy on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Eric Joseph Initiated (TERN) at Buy and Held Target at $32 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Michael Petusky Upgraded (XRAY) to Buy and Held Target at $71 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Paul Knight Maintained (XGN) at Buy with Increased Target to $33 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Thomas Allen Maintained (XHR) at Sell with Increased Target to $14 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (XENE) at Buy with Increased Target to $28 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Serge Belanger Maintained (XENE) at Strong Buy with Increased Target to $25 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Robert Ohmes Maintained (TGT) at Strong Buy and Held Target at $260 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Andrew Berens Maintained (AZN) at Buy with Decreased Target to $63 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (AXSM) at Buy with Increased Target to $104 on, Mar 2nd, 2021
[ 12:00 AM ] - WOPRAI
Michael Cyprys Initiated (TW) at Buy and Held Target at $90 on, Mar 2nd, 2021
Mon, March 1, 2021
[ 12:00 AM ] - WOPRAI
Myles Walton Maintained (UAL) at Strong Buy with Increased Target to $67 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Matthew Cabral Initiated (TU) at Hold and Held Target at $33 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Kristine Liwag Maintained (BA) at Buy with Increased Target to $250 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (BAC) at Sell with Increased Target to $38 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Joseph Moore Maintained (WDC) at Buy with Increased Target to $84 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Michael Lasser Maintained (ULTA) at Strong Buy with Increased Target to $365 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Bob Brackett Downgraded (APA) to Hold and Held Target at $20 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Matthew Cabral Initiated (TIXT) at Hold and Held Target at $33 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
James Faucette Initiated (TIXT) at Hold and Held Target at $31 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Maggie Nolan Initiated (TIXT) at Buy on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Tien-Tsin Huang Initiated (TIXT) at Buy and Held Target at $35 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Hamed Khorsand Maintained (TPL) at Strong Buy with Increased Target to $567 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (YMAB) at Strong Buy with Increased Target to $70 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (TFC) at Hold with Increased Target to $65 on, Mar 1st, 2021
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (TBPH) at Buy with Decreased Target to $30 on, Mar 1st, 2021

Vikram Purohit Maintained (TBPH) at Buy with Decreased Target to $30 on, Mar 1st, 2021


Published on 2024-10-27 15:48:43 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $31 to $30 on, Mar 1st, 2021.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram

  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $41 on, Wednesday, February 24th, 2021
  • Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $30 on, Tuesday, November 24th, 2020
Contributing Sources